Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

MULTISCOPE Multimode Nonlinear Fiber Based Endoscopic Imaging and Treatment

Coordinator
Universita Degli Studi Di Roma La Sapienza, Italy
Runs
1 December 2024 to 30 November 2028
Status
Running
EU funding
€3.1m
Total cost
€3.1m
Partners
7 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101185664

What the project is doing

In the project's own words, from its summary on CORDIS.

MULTISCOPE introduces a revolutionary photonic technology that represents a significant advancement in the field of optical diagnostics and therapy. Our approach is based on cutting-edge research into pulse propagation within nonlinear complex structures. We are developing an endoscopic device that seamlessly combines optical biopsy and cold atmospheric plasma treatment. This dual-functionality device harnesses the spatiotemporal control of powerful light in multimode fibers, which were previously overlooked due to concerns about excessive light destructuring.

We leverage the remarkable progress in the development of the latest optical fibers and in the precise control of light within multimode guides, enabling us to harness the power of plasma, the fourth state of matter. Initially, our focus is on gastrointestinal (GI) endoscopy, but our ultimate goal is to extend this technology to all areas of medical diagnostics where there is a pressing need for reliable tools for ""optical biopsy"" and ""instant pathology."" These tools are crucial for real-time diagnosis but have not yet reached the level of trustworthiness required for widespread use.

Endoscopy is a vital tool for diagnosing and treating GI disorders, offering a safe and effective approach. However, the current standard of care still relies on histopathology for conclusive cancer diagnosis. This leads to significant delays in initiating treatment and incurs high costs. Our project is set to transform this landscape by bringing to life the long-anticipated concept of real-time, in-vivo optical diagnosis, often referred to as ""optical biopsy"".

Our groundbreaking approach seamlessly integrates endoscopic capabilities with cold atmospheric plasma therapy, which employs controlled plasma jets to precisely target and eliminate cancer cells by inducing cellular apoptosis. By combining plasma therapy with optical biopsy, we not only provide real-time diagnosis but also offer immediate therapeutic intervention.""

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Roma La SapienzaRomaItalyCoordinator
Erbe Elektromedizin GmbHTübingenGermanyParticipant
Centre National De La Recherche Scientifique CNRSParisFranceThird party
Universite De LimogesLimogesFranceParticipant
Fondazione Policlinico Universitario Agostino Gemelli IrccsRomaItalyParticipant
Universita Cattolica Del Sacro CuoreMilanoItalyParticipant
Ist-Id Associacao Do Instituto Superior Tecnico Para a Investigacao E O DesenvolvimentoLisboaPortugalParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI